Pharmacokinetic and pathophysiologic covariates influencing treatment outcomes with T-DM1 in patients with HER2-positive metastatic breast cancer (MBC). Background: BM is a common occurrence in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results